[HTML] frontiersin.org

[HTML][HTML] A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma—Toward a Better Mimicry of the in vivo Tumor Microenvironment

P Gupta, PA Pérez-Mancera, H Kocher… - … in Bioengineering and …, 2020 - frontiersin.org
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly
disease. This has been primarily attributed to (i) its late diagnosis and (ii) its high resistance …
被引用次数：51 相关文章

[引用][C] A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma-Toward a Better Mimicry of the in vivo Tumor Microenvironment

P Gupta, PA Perez-Mancera, H Kocher… - Frontiers in …, 2020 - jglobal.jst.go.jp
A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma-Toward
a Better Mimicry of the in vivo Tumor Microenvironment | Article Information | J-GLOBAL Art J-GLOBAL …

A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma—Toward a Better Mimicry of the in vivo Tumor Microenvironment

P Gupta, PA Perez-Mancera, H Kocher… - Frontiers in … - openresearch.surrey.ac.uk
A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma—Toward
a Better Mimicry of the in vivo Tumor Microenvironment - University of Surrey Logo image …

[引用][C] A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma—Toward a Better Mimicry of the in vivo Tumor Microenvironment

P Gupta, PA Pérez-Mancera… - Frontiers in …, 2020 - eprintspublications.npl.co.uk
A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma—Toward
a Better Mimicry of the in vivo Tumor Microenvironment | NPL Publications Home < back to …

A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma-Toward a Better Mimicry of the in vivo Tumor Microenvironment.

P Gupta, PA Pérez-Mancera, H Kocher… - Frontiers in …, 2020 - europepmc.org
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly
disease. This has been primarily attributed to (i) its late diagnosis and (ii) its high resistance …
[PDF] scienceopen.com

[PDF][PDF] A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma—Toward a Better Mimicry of the in vivo Tumor Microenvironment

P Gupta, PA Pérez-Mancera, H Kocher, A Nisbet… - scienceopen.com
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly
disease. This has been primarily attributed to (i) its late diagnosis and (ii) its high resistance …
[HTML] nih.gov

[HTML][HTML] A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma—Toward a Better Mimicry of the in vivo Tumor Microenvironment

P Gupta, PA Pérez-Mancera, H Kocher… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly
disease. This has been primarily attributed to (i) its late diagnosis and (ii) its high resistance …

A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma-Toward a Better Mimicry of the in vivo Tumor Microenvironment

P Gupta, PA Pérez-Mancera… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly
disease. This has been primarily attributed to (i) its late diagnosis and (ii) its high resistance …
[PDF] qmul.ac.uk

[PDF][PDF] A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma-Toward a Better Mimicry of the in vivo Tumor Microenvironment

P Gupta, PA Perez-Mancera, H Kocher… - FRONTIERS IN …, 2020 - qmro.qmul.ac.uk
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly
disease. This has been primarily attributed to (i) its late diagnosis and (ii) its high resistance …
[PDF] core.ac.uk

[PDF][PDF] A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma—Toward a Better Mimicry of the in vivo Tumor Microenvironment

P Gupta, PA Pérez-Mancera, H Kocher, A Nisbet… - core.ac.uk
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly
disease. This has been primarily attributed to (i) its late diagnosis and (ii) its high resistance …